Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Esperion Therapeutics, Inc. (ESPR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues  78.4227.5148.40.00.00.00.00.0
            Revenue growth  -65.5%53.4%      
Cost of goods sold  14.22.40.00.00.00.00.00.0
Gross profit  64.2225.2148.40.00.00.00.00.0
            Gross margin  81.9%98.9%100.0%     
Selling, general and administrative   [+]185.0199.665.933.121.418.320.210.9
Research and development  106.0146.9175.6171.5147.657.929.825.3
EBITDA   [+]-226.1-120.8-92.8-204.3-168.7-75.9-49.8-36.1
            EBITDA margin  -288.2%-53.1%-62.5%     
Depreciation and amortization  0.60.50.30.30.30.30.20.2
EBIT   [+]-226.7-121.4-93.1-204.6-169.0-76.2-50.0-36.2
            EBIT margin  -289.0%-53.3%-62.8%     
Interest expense  46.422.78.10.00.2 0.50.3
Other income (expense), net   [+]4.00.54.12.82.21.20.80.1
Pre-tax income  -269.1-143.6-97.2-201.8-167.0-75.0-49.8-36.4
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -269.1-143.6-97.2-201.8-167.0-75.0-49.8-36.4
            Net margin  -343.0%-63.1%-65.5%     
   
Basic EPS   [+]($9.31)($5.23)($3.59)($7.54)($6.98)($3.33)($2.26)($2.22)
Diluted EPS   [+]($9.31)($5.23)($3.59)($7.54)($6.98)($3.33)($2.26)($2.22)
   
Shares outstanding (basic)   [+]28.927.527.126.823.922.522.016.4
Shares outstanding (diluted)   [+]28.927.527.126.823.922.522.016.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy